NICE has recommended peginterferon alfa in combination with ribavirin as an option for treating chronic Hepatitis C in children and...
Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults (see sections 4.2, 4.4, and 5.1). Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) not previously treated and without liver decompensation (see sections 4.2, 4.4 and 5.1).
Ribavirin is indicated in combination with other medicinal products except peginterferon alfa-2a and peginterferon alfa-2b, for the treatment of chronic hepatitis C